Assessment and management of pulmonary alveolar proteinosis in a reference center

Orphanet Journal of Rare Diseases

Volumn 8, Issue 1, 2013, Pages

  Campo, Ilaria ^a   Mariani, Francesca ^a   Rodi, Giuseppe ^a   Paracchini, Elena ^a   Tsana, Eric ^a   Piloni, Davide ^a   Nobili, Isabella ^a   Kadija, Zamir ^a   Corsico, Angelo ^a   Cerveri, Isa ^a   Chalk, Claudia ^b   Trapnell, Bruce C ^b   Braschi, Antonio ^a   Tinelli, Carmine ^c   Luisetti, Maurizio ^a  

^a UNIVERSITY OF PAVIA   (Italy)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^c FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; CYTOKERATIN 19 FRAGMENT; LACTATE DEHYDROGENASE; LUNG SURFACTANT;

ARTERIAL OXYGEN TENSION; ARTICLE; ASYMPTOMATIC DISEASE; AUTOIMMUNE DISEASE; COMPUTER ASSISTED TOMOGRAPHY; COUGHING; DISEASE COURSE; DISEASE SEVERITY; DYSPNEA; FEMALE; FEVER; FORCED VITAL CAPACITY; HUMAN; IDIOPATHIC DISEASE; ITALY; LUNG ALVEOLUS PROTEINOSIS; LUNG DIFFUSION CAPACITY; LUNG FUNCTION; LUNG LAVAGE; MAJOR CLINICAL STUDY; MALE; SMOKING; SPUTUM;

ADULT; FEMALE; HUMANS; MALE; MIDDLE AGED; OCCUPATIONAL EXPOSURE; PULMONARY ALVEOLAR PROTEINOSIS; PULMONARY SURFACTANTS; REFERENCE VALUES;

EID: 84874811053     PISSN: None     EISSN: 17501172     Source Type: Journal    
DOI: 10.1186/1750-1172-8-40     Document Type: Article

References (21)

1. Pulmonary alveolar proteinosis. Luisetti M, Trapnell BC, Interstitial Lung Disease Shelton CT: Peoples' Medical Publishing House USA, Schwarz MI, King TE, 2010 1079 1093
2. Pulmonary alveolar proteinosis. Trapnell BC, Whitsett JA, Nakata K, N Engl J Med 2003 349 26 2527 2539 10.1056/NEJMra023226 14695413 (Pubitemid 38010079)
3. Prevalence of rare diseases, Bibliographic data, Orphanet Report Series, Rare diseases collection November 2011, Number 1: Listed in alphabetical order of diseases http://www.orpha.net/orphacom/cahiers/docs/GB/Prevalence-of-rare- diseases-by-alphabetical-list.pdf
4. Idiopathic pulmonary alveolar proteinosis as an autoimmune disease with neutralizing antibody against granulocyte/macrophage colony-stimulating factor. Kitamura T, Tanaka N, Watanabe J, Uchida K, Kanegasaki S, Yamada Y, Nakata K, J Exp Med 1999 190 6 875 880 10.1084/jem.190.6.875 10499925 (Pubitemid 29451632)
5. Lungs of patients with idiopathic pulmonary alveolar proteinosis express a factor which neutralizes granulocyte-macrophage colony stimulating factor. Tanaka N, Watanabe J, Kitamura T, Yamada Y, Kanegasaki S, Nakata K, FEBS Lett 1999 442 2-3 246 250 9929010 (Pubitemid 29070842)
6. Therapy options in pulmonary alveolar proteinosis. Luisetti M, Kadija Z, Mariani F, Rodi G, Campo I, Trapnell BC, Ther Adv Respir Dis 2010 4 239 248 10.1177/1753465810378023 20647242
7. Pulmonary alveolar proteinosis: a New technique and rationale for treatment. Ramirez J, Schultz R, Dutton R, Arch Intern Med 1963 112 419 431 10.1001/archinte.1963.03860030173021 14045290
8. Therapeutic efficacy of granulocyte macrophage colony-stimulating factor in patients with idiopathic acquired alveolar proteinosis. Seymour JF, Presneill JJ, Schoch OD, Am J Respir Crit Care Med 2001 163 524 531 11179134 (Pubitemid 32158540)
9. Pulmonary alveolar phospholipoproteinosis: experience with 34 cases and a review. Prakash UB, Barham SS, Carpenter HA, Dines DE, Marsh HM, Mayo Clin Proc 1987 62 6 499 518 10.1016/S0025-6196(12)65477-9 3553760 (Pubitemid 17084821)
10. Characteristics of a large cohort of patients with autoimmune pulmonary alveolar proteinosis in japan. Inoue Y, Trapnell BC, Tazawa R, Arai T, Takada T, Hizawa N, Kasahara Y, Tatsumi K, Hojo M, Ichiwata T, Tanaka N, Yamaguchi E, Eda R, Oishi K, Tsuchihashi Y, Kaneko C, Nukiwa T, Sakatani M, Krischer JP, Nakata K, Japanese center of the rare lung diseases consortium, Am J Respir Crit Care Med 2008 177 7 752 762 10.1164/rccm.200708-1271OC 18202348 (Pubitemid 351490562)
11. Pulmonary alveolar proteinosis in China: a systematic review of 241 cases. Xu Z, Jing J, Wang H, Xu F, Wang J, Respirology 2009 14 5 761 766 10.1111/j.1440-1843.2009.01539.x 19476601
12. Pulmonary alveolar proteinosis: new insights from a single-center cohort of 70 patients. Bonella F, Bauer PC, Griese M, Ohshimo S, Guzman J, Costabel U, Respir Med 2011 105 12 1908 1916 10.1016/j.rmed.2011.08.018 21900000
13. Rare diffuse diseases of the lung. Pulmonary alveolar proteinosis, lymphangioleiomyomatosis, amyloidosis. Morbini P, Guddo F, Contini P, Luisetti M, Schiavina M, Zompatori M, Pathologica 2010 102 547 556 21428118
14. Long term durable benefit after whole lung lavage in pulmonary alveolar proteinosis. Beccaria M, Luisetti M, Rodi G, Corsico A, Zoia MC, Colato S, Pochetti P, Braschi A, Pozzi E, Cerveri I, Eur Respir J 2004 23 526 531 10.1183/09031936.04.00102704 15083749 (Pubitemid 38455992)
15. Epidemiological and clinical features of idiopathic pulmonary alveolar proteinosis in Japan. Inoue Y, Nakata K, Arai T, Tazawa R, Hamano E, Nukiwa T, Kudo K, Keicho N, Hizawa N, Yamaguchi E, Eda R, Oishi K, Maeda Y, Koreeda Y, Kodo N, Sakatani M, Respirology 2006 11 55 S60 10.1111/j.1440-1843.2006.00810.x 16423273
16. Pulmonary alveolar proteinosis in workers at an indium processing facility. Cummings KJ, Donat WE, Ettensohn DB, Roggli VL, Ingram P, Kreiss K, Am J Respir Crit Care Med 2010 181 5 458 464 10.1164/rccm.200907-1022CR 20019344
17. Hereditary pulmonary alveolar proteinosis. Pathogenesis, presentation, diagnosis, and therapy. Suzuki T, Sakagami T, Young LR, Carey BC, Wood RE, Luisetti M, Wert SE, Rubin BK, Kevill K, Chalk C, Whitsett JA, Stevens C, Nogee LM, Campo I, Trapnell BC, Am J Respir Crit Care Med 2010 182 1292 1304 10.1164/rccm.201002-0271OC 20622029
18. In Lysinuric protein Intolerance system y + L activity is defective in monocytes and in GM-CSF-differentiated macrophages. Barilli A, Rotoli BM, Visigalli R, Bussolati O, Gazzola GC, Kadija Z, Rodi G, Mariani F, Ruzza ML, Luisetti M, Dall'Asta V, Orphanet J Rare Dis 2010 5 32 10.1186/1750-1172-5-32 21110863
19. Successful whole lung lavage in pulmonary alveolar proteinosis secondary to lysinuric protein intolerance: a case report. Ceruti M, Rodi G, Stella GM, Adami A, Bolongaro A, Baritussio A, Pozzi E, Luisetti M, Orphanet J Rare Dis 2007 2 14 10.1186/1750-1172-2-14 17386098
20. Elevation of tumour markers in serum and bronchoalveolar lavage fluid in pulmonary alveolar proteinosis. Hirakata Y, Kobayashi J, Sugama Y, Kitamura S, Eur Respir J 1995 8 689 696 7656937
21. Increased carcinoembryonic antigen concentrations in sera and bronchoalveolar lavage fluids of patients with pulmonary alveolar proteinosis. Fujishima T, Honda Y, Shijubo N, Takahashi H, Abe S, Respiration 1995 626 317 321